Taiwan Advance Bio-Pharmaceutical Inc (TABP, 台灣尖端先進生技醫藥) and General Biologicals Corp (GBC, 普生股份) yesterday separately said that they have a good chance of being chosen to produce a rapid screening reagent for COVID-19.
The two were among 10 companies that attended a conference with Academia Sinica last week.
Yesterday’s announcement came after the institute on Sunday announced that it has synthesized a monoclonal antibody that can quickly identify the coronavirus that causes COVID-19.
“Academia Sinica said in the meeting that it has certain criteria to select qualified manufacturers for the test kits. It seems that we have a chance and we will keep in close contact with the institute,” TABP deputy director Chang Chih-feng (張志鋒) told the Taipei Times by telephone.
TABP, which focuses on test kits for antibiotics and pesticide residue in food, produces about 12,000 kits per week at its factory in New Taipei City, Chang said.
“We could allocate production capacity to mass produce the reagents by running the machines in extra shifts and recruit more operators,” he said.
As TABP has not produced reagents for human use, it might need to gain regulatory approval before starting production, he added.
GBC president Frank Lin (林孟德) said by phone that the supplier of diagnostic test kits for hepatitis B, C and D has a better chance of winning the contract, as it has been producing reagents for human use for more than 30 years.
“The production should not be difficult, as the institute is expected to provide the monoclonal antibody, which we can rapidly regenerate in mice,” Lin said.
“Synthesizing the monoclonal antibody that can identify COVID-19 is the more challenging part in the development of reagents, but we do not need to worry about it,” he said.
Both companies said they would continue negotiating with the institute over whether it would contract them to produce the kits.
The other companies that attended the meeting included AsiaGen Corp (亞洲基因), Firstep Bioresearch Inc (聯華生技), Panion & BF Biotech Inc (寶齡富錦), Formosa Biomedical Technology Corp (台塑生醫), Lihpao Life Science Corp (麗寶生醫), iXensor Co Ltd (安盛生科) and Eternal Materials Co Ltd (長興材料), said the Ministry of Economic Affairs, which helped organize the meeting.
“Many companies were interested in collaborating with Academia Sinica, as the business might be lucrative. Rapid screening reagents are not as accurate, but could be widely applied,” a ministry official said.
Medigen Vaccine Biologics Corp (高端疫苗), which last month sent an application to the health regulator for its new COVID-19 reagent that utilizes a polymerase chain reaction technique, said it would continue to focus on its own product, spokesman Leo Lee (李思賢) said.
DECOUPLING? In a sign of deeper US-China technology decoupling, Apple has held initial talks about using Baidu’s generative AI technology in its iPhones, the Wall Street Journal said China has introduced guidelines to phase out US microprocessors from Intel Corp and Advanced Micro Devices Inc (AMD) from government PCs and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft Corp’s Windows operating system and foreign-made database software in favor of domestic options, the report said. Chinese officials have begun following the guidelines, which were unveiled in December last year, the report said. They order government agencies above the township level to include criteria requiring “safe and reliable” processors and operating systems when making purchases, the newspaper said. The US has been aiming to boost domestic semiconductor
Nvidia Corp earned its US$2.2 trillion market cap by producing artificial intelligence (AI) chips that have become the lifeblood powering the new era of generative AI developers from start-ups to Microsoft Corp, OpenAI and Google parent Alphabet Inc. Almost as important to its hardware is the company’s nearly 20 years’ worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia’s CUDA software platform to build AI and other apps. Now a coalition of tech companies that includes Qualcomm Inc, Google and Intel Corp plans to loosen Nvidia’s chokehold by going
ENERGY IMPACT: The electricity rate hike is expected to add about NT$4 billion to TSMC’s electricity bill a year and cut its annual earnings per share by about NT$0.154 Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has left its long-term gross margin target unchanged despite the government deciding on Friday to raise electricity rates. One of the heaviest power consuming manufacturers in Taiwan, TSMC said it always respects the government’s energy policy and would continue to operate its fabs by making efforts in energy conservation. The chipmaker said it has left a long-term goal of more than 53 percent in gross margin unchanged. The Ministry of Economic Affairs concluded a power rate evaluation meeting on Friday, announcing electricity tariffs would go up by 11 percent on average to about NT$3.4518 per kilowatt-hour (kWh)
OPENING ADDRESS: The CEO is to give a speech on the future of high-performance computing and artificial intelligence at the trade show’s opening on June 3, TAITRA said Advanced Micro Devices Inc (AMD) chairperson and chief executive officer Lisa Su (蘇姿丰) is to deliver the opening keynote speech at Computex Taipei this year, the event’s organizer said in a statement yesterday. Su is to give a speech on the future of high-performance computing (HPC) in the artificial intelligence (AI) era to open Computex, one of the world’s largest computer and technology trade events, at 9:30am on June 3, the Taiwan External Trade Development Council (TAITRA) said. Su is to explore how AMD and the company’s strategic technology partners are pushing the limits of AI and HPC, from data centers to